France· FR:65228400
HUMALOG 100 UI/ml, solution injectable en flacon
A medicinal product containing insuline lispro recombinante, registered in France by ELI LILLY NEDERLAND BV (PAY-BAS), on the national reimbursement list.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- INSULINE LISPRO RECOMBINANTE
- Manufacturer
- ELI LILLY NEDERLAND BV (PAY-BAS)
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- cip1334009341426801 flacon(s) en verre de 10 mlEUR 14.31
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Insuline lispro recombinante in 17 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomAdmelog 100units/ml solution for injection 10ml vialsSanofi
- CzechiaBYSUMLOGGan & Lee Pharmaceuticals Europe GmbH, Düsseldorf
- United StatesADMELOGREMEDYREPACK INC.
- FinlandBysumlogGan & Lee Pharmaceuticals Europe GmbH
- BelgiumBysumlog 100 U/mlGan & Lee Pharmaceuticals Europe
- SwedenBysumlog 100 E/ml Injektionsvätska, lösning i förfylld injektionspennaSandoz GmbH
- IcelandBysumlogGan & Lee Pharmaceuticals Europe GmbH
- NetherlandsBysumlog 100 eenheden/ml oplossing voor injectie in een voorgevulde penGan & Lee Pharmaceuticals Europe GmbH
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Bysumlog, Humalog
- Liechtenstein · Bysumlog, Humalog
- Norway · Bysumlog, Humalog
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ca5f7d00-8449-4495-90c8-6d11e853c07c GET /v1/drugs/ca5f7d00-8449-4495-90c8-6d11e853c07c?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "65228400",
"date_amm": "1996-04-30",
"type_amm": "Procédure centralisée",
"numero_ue": "EU/1/96/007",
"substance": "INSULINE LISPRO RECOMBINANTE",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "solution injectable",
"voies_administration": "intramusculaire;intraveineuse;sous-cutanée",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about insuline lispro recombinante.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.